Last reviewed · How we verify
NCT03512509: POSAT
Comparison of Low GI and High GI Potatoes in Relation to Satiety (POSAT)
NA trial testing Low glycaemic potato in Obesity in 22 participants. Completed in 20 August 2018.
30 April 2018
Quick facts
| Lead sponsor | Anne Birgitte Raben |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | single |
| Primary purpose | prevention |
| Enrollment | 22 |
| Start date | 5 February 2018 |
| Primary completion | 30 April 2018 |
| Estimated completion | 20 August 2018 |
| Sites | 1 location across Denmark |
Drugs / interventions tested
- Low glycaemic potato
- High glycaemic potato
Conditions studied
- Obesity — all drugs for Obesity →
Sponsor
Anne Birgitte Raben
Who can join
Adults 18 to 40, male only, with Obesity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study is a single-blind, randomised crossover study, investigating how a high glycaemic potato affects satiety in humans compared to a low glycaemic potato. This is done to shed further light on the discussion about whether potatoes with a high glycaemic index increases the risk of overweight and obesity and thus indirectly type 2 diabetes and cardiovascular disease.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Comparison of Low Glycaemic Index and High Glycaemic Index Potatoes in Relation to Satiety: A Single-Blinded, Randomised Crossover Study in Humans.
Andersen SSH, Heller JMF, Hansen TT, Raben A. · · 2018 · cited 13× · PMID 30423848 · DOI 10.3390/nu10111726
Verify or expand the search:
- PubMed search for NCT03512509
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Obesity
Currently open trials in the same condition.
- NCT07403604 — Effect of Insulin Lowering on Lipogenesis · Phase 1 · recruiting
- NCT07509307 — AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee · Phase 3 · recruiting
- NCT07272837 — Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass · recruiting
- NCT07481630 — A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoart · Phase 3 · recruiting
- NCT07527195 — Understanding the Effect of CagriSema, Cagrilintide, and Semaglutide on Muscle Health (Role of Amylin Signature in Muscl · Phase 1 · recruiting
Other Anne Birgitte Raben trials
Trials by the same sponsor.
- NCT04226911 — Sweeteners and Sweetness Enhancers: Prolonged Effects on Health, Obesity and Safety · NA · completed
- NCT03656367 — Designing Biofunctional Dairy Foods: Matrix Structure of Dairy Products in Relation to Lipaemia · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03512509 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Anne Birgitte Raben
- Last refreshed: 11 October 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03512509.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing